Chardan Capital Initiates Coverage On MannKind with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsInitiationPrice Target
Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.
Chardan Capital analyst Andreas Argyrides initiates coverage on MannKind (NASDAQ:MNKD) with a Buy rating and announces Price Target of $10.